Cardiovascular diseases (CVDs) have become a serious threat to human life and health.
Though many drugs acting via different mechanism of action are available in the market as …

Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and
mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are …

Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …

Administration of drugs and other therapeutic agents has been the central strategy of
contemporary medicine for cardiovascular disease. The use of a drug delivery system (DDS) …

Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …

Nanoparticles are exclusively suitable for studying and developing potential therapies
against cardiovascular diseases (CVD) because of their size, fine-tunable properties, and …

Cardiovascular disease (CVD) is currently one of the primary causes of mortality and
morbidity worldwide. Nanoparticles (NPs) are playing increasingly important roles in …

Nanotechnology has been applied extensively in drug delivery to improve the therapeutic
outcomes of various diseases. Tremendous efforts have been focused on the development …

Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …

In the past few decades, there has been explosive growth in the construction of nanoparticle-
based drug delivery systems (NDDSs), namely nanomedicines, owing to their unique …